SCHEMBL20955233

SCHEMBL20955233

COc1ccc2c(c1)C1(CCN(C(=O)OCc3ccccc3)CC1)CN2C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 1/20 0.52
SCN9A Q15858 1/20 0.52
XIAP P98170 1/20 0.46
BIRC2 Q13490 1/20 0.46
P2RY1 P47900 1/20 0.46
HDAC1 Q13547 3/20 0.45
HDAC8 Q9BY41 3/20 0.45
HDAC6 Q9UBN7 3/20 0.45
CASP1 P29466 1/20 0.45
SLC2A1 P11166 1/20 0.44
YAP1 P46937 1/20 0.42
HTT P42858 1/20 0.42
TACR1 P25103 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
APP P05067 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20955202 0.89 XIAP (0.46) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL15676881 0.89 HDAC1 (0.47) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL2800892 0.89 HDAC1 (0.56) XIAPBIRC2P2RY1HDAC1HDAC8
SCHEMBL20955089 0.89 HDAC1 (0.49) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL20954935 0.88 HDAC1 (0.47) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL8221795 0.85 HDAC1 (0.56) XIAPBIRC2P2RY1HDAC1HDAC8
SCHEMBL15677075 0.84 MEN1 (0.47) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL20954995 0.84 XIAP (0.52) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL20955412 0.84 XIAP (0.64) SCN5ASCN9AXIAPBIRC2P2RY1
SCHEMBL20954809 0.83 HDAC1 (0.51) SCN5ASCN9AXIAPBIRC2P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3480198-B1 NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF RIKEN (JP) 2021-05-05 EP disclosed
EP-3480198-A1 NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF RIKEN (JP) 2019-05-08 EP disclosed